Ginkgo Bioworks (DNA) Misses Q4 EPS by 1c

Ginkgo Bioworks (NYSE: DNA) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $34.76 million versus the consensus estimate of $42.5 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Playboy to buy back 16.6M shares from Fortress at $1.05 each
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group